BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ATF1, TREB36, 466, ENSG00000123268, P18846
40 results:

  • 1. Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data Study.
    Ribelles N; Pascual J; Galvez-Carvajal L; Ruiz-Medina S; Garcia-Corbacho J; Benitez JC; Dominguez-Recio ME; Torres E; Oliva L; Zalabardo M; Rueda A; Alba E
    JCO Glob Oncol; 2024 Mar; 10():e2300363. PubMed ID: 38513186
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Late complications and 5 years outcomes of robotic partial nephrectomy in France: prospective assessment in the French kidney Cancer Research Network (UroCCR 10).
    Margue G; Ingels A; Bensalah K; Doumerc N; Vaessen C; Roupret M; Audenet F; Mejean A; Bruyere F; Olivier J; Baumert H; Michel C; Paparel P; Parier B; Sebe P; Long JA; Lang H; Lebret T; Patard JJ; Bernhard JC
    World J Urol; 2023 Aug; 41(8):2281-2288. PubMed ID: 37407720
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Mean features of the nephron- sparing surgery in older patients with localized renal cell carcinoma].
    Kotov SV; Nemenov AA; Yusufov AG; Guspanov RI; Pulbere SA; Nemenova DM
    Urologiia; 2022 Dec; (6):84-88. PubMed ID: 36625619
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outcomes of Bosniak Classification Version 2019 Class IIF Cystic Renal Masses at Imaging Surveillance.
    Shen L; Yoon L; Chung BI; Kamaya A; Tse JR
    AJR Am J Roentgenol; 2023 May; 220(5):705-717. PubMed ID: 36416398
    [No Abstract]    [Full Text] [Related]  

  • 5. Acute kidney injury in advanced lung cancer patients treated with PD-1 inhibitors: a single center observational study.
    Liu K; Qin Z; Ge Y; Bian A; Xu X; Wu B; Xing C; Mao H
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5061-5070. PubMed ID: 36326913
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pathologic fracture in metastatic kidney cancer: Identifying widening disparities and opportunity for quality improvement.
    Bhanvadia RR; Baky FJ; Ashbrook CQ; Lotan Y; Woldu SL
    Urol Oncol; 2022 Aug; 40(8):384.e1-384.e8. PubMed ID: 35662499
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A meta-analysis of the platelet-lymphocyte ratio: A notable prognostic factor in renal cell carcinoma.
    Zhou X; Luo G
    Int J Biol Markers; 2022 Jun; 37(2):123-133. PubMed ID: 35238678
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Role of Surgery in Antenatal Ovarian Torsion: Retrospective Evaluation of 28 Cases and Review of the Literature.
    Toker Kurtmen B; Divarci E; Ergun O; Ozok G; Celik A
    J Pediatr Adolesc Gynecol; 2022 Feb; 35(1):18-22. PubMed ID: 34454073
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study.
    Gu L; Peng C; Zhang F; Fang C; Guo G
    Orphanet J Rare Dis; 2021 Jun; 16(1):277. PubMed ID: 34127034
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pure retroperitoneal laparoscopic radical nephrectomy and thrombectomy with delayed occlusion of the proximal inferior vena cava (DOPI) technique for renal tumor with level II-III venous tumor thrombus.
    Liu Z; Hong P; Zhu G; Zhang L; Zhao X; Tang S; Yang F; Tian X; Wang G; Zhang S; Zhang H; Huang Y; Liu C; Liu C; Ma L
    BMC Cancer; 2021 May; 21(1):627. PubMed ID: 34044812
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Real-World Outcomes Among US Veterans Health Administration Patients Newly Diagnosed with Metastatic Renal Cell Carcinoma and Treated with First-Line Monotherapy.
    Bhanegaonkar A; Pandya S; Zheng Y; Kim R; Krulewicz S; Kasturi V; Phatak H
    Adv Ther; 2021 May; 38(5):2644-2661. PubMed ID: 33866526
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mast cell density in metastatic renal cell carcinoma: Association with prognosis and tumour-infiltrating lymphocytes.
    Yao J; Xi W; Chen X; Xiong Y; Zhu Y; Wang H; Hu X; Guo J
    Scand J Immunol; 2021 Apr; 93(4):e13006. PubMed ID: 33275792
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Diagnostic accuracy of signal loss in in-phase gradient-echo images for differentiation between small renal cell carcinoma and lipid-poor angiomyolipomas.
    Lima FVA; Elias J; Chahud F; Reis RB; Muglia VF
    Br J Radiol; 2020 Apr; 93(1108):20190975. PubMed ID: 31971819
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Epidemiological Characteristics of 1196 Patients with Spinal Metastases: A Retrospective Study.
    Wang F; Zhang H; Yang L; Yang XG; Zhang HR; Li JK; Qiao RQ; Hu YC
    Orthop Surg; 2019 Dec; 11(6):1048-1053. PubMed ID: 31755205
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Relationship between plasma Atherogenic index and final pathology of Bosniak III-IV renal masses: a retrospective, single-center study.
    Karabay E; Karsiyakali N; Duvar S; Tosun C; Aslan AR; Yucebas OE
    BMC Urol; 2019 Sep; 19(1):85. PubMed ID: 31519200
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Management Strategies and Patient Selection After a Hospital Funding Reform for Prostate Cancer Surgery in Canada.
    Wettstein MS; Palmer KS; Kulkarni GS; Paterson JM; Ling V; Lapointe-Shaw L; Li AH; Brown A; Taljaard M; Ivers N
    JAMA Netw Open; 2019 Aug; 2(8):e1910505. PubMed ID: 31469400
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Incidence and relative risk for developing cancers in women with gestational diabetes mellitus: a nationwide cohort study in Taiwan.
    Peng YS; Lin JR; Cheng BH; Ho C; Lin YH; Shen CH; Tsai MH
    BMJ Open; 2019 Feb; 9(2):e024583. PubMed ID: 30796123
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Expression and bioinformatics analysis of long-chain non-coding RNA PVT1 in tumors].
    Wang M; Gao W; Bai YF; Lu DH; Teng LH
    Zhonghua Bing Li Xue Za Zhi; 2017 Jul; 46(7):485-490. PubMed ID: 28728223
    [No Abstract]    [Full Text] [Related]  

  • 19. Association of genetic variations in RTN4 3'-UTR with risk for clear cell renal cell carcinoma.
    Pu Y; Chen P; Zhou B; Zhang P; Wang Y; Song Y; Zhang L
    Fam Cancer; 2018 Jan; 17(1):129-134. PubMed ID: 28687970
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.
    Gong X; Siprashvili Z; Eminaga O; Shen Z; Sato Y; Kume H; Homma Y; Ogawa S; Khavari PA; Pollack JR; Brooks JD
    Oncotarget; 2017 Mar; 8(12):18657-18669. PubMed ID: 28423633
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.